Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?

被引：9

作者：

Messerli, FH ^{[1
]}

Sichrovsky, T ^{[1
]}

机构：

[1] St Lukes Roosevelt Hosp, New York, NY 10025 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 96卷 / 06期

关键词：

D O I：

10.1016/j.amjcard.2005.05.038

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：872 / 873

页数：2

共 14 条

[1] Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure [J].

Aw, TJ ;

Haas, SJ ;

Liew, D ;

Krum, H .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (05) :490-496

[2] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].

Bresalier, RS ;

Sandler, RS ;

Quan, H ;

Bolognese, JA ;

Oxenius, B ;

Horgan, K ;

Lines, C ;

Riddell, R ;

Morton, D ;

Lanas, A ;

Konstam, MA ;

Baron, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102

[3] Selective COX-2 inhibition improves endothelial function in coronary artery disease [J].

Chenevard, R ;

Hürlimann, D ;

Béchir, M ;

Enseleit, F ;

Spieker, L ;

Hermann, M ;

Riesen, W ;

Gay, S ;

Gay, RE ;

Neidhart, M ;

Michel, B ;

Lüscher, TF ;

Noll, G ;

Ruschitzka, F .

CIRCULATION, 2003, 107 (03) :405-409

[4] Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study [J].

Graham, DJ ;

Campen, D ;

Hui, R ;

Spence, M ;

Cheetham, C ;

Levy, G ;

Shoor, S ;

Graham, D .

LANCET, 2005, 365 (9458) :475-481

[5] Treating osteoarthritis with cyclooxygenase-2-specific inhibitors - What are the benefits of avoiding blood pressure destabilization? [J].

Grover, SA ;

Coupal, L ;

Zowall, H .

HYPERTENSION, 2005, 45 (01) :92-97

[6]

Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8

[7]

Liew Danny, 2002, Curr Opin Investig Drugs, V3, P1468

[8] Risk of cardiovascular events associated with selective COX-2 inhibitors [J].

Mukherjee, D ;

Nissen, SE ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08) :954-959

[9]

Pickering G, 1961, NATURE ESSENTIAL HYP

[10] Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention [J].

Solomon, SD ;

McMurray, JJV ;

Pfeffer, MA ;

Wittes, J ;

Fowler, R ;

Finn, P ;

Anderson, WF ;

Zauber, A ;

Hawk, E ;

Bertagnolli, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1071-1080

← 1 2 →